UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Koninklijke Philips Electronics N.V. |
||||
(Translation of registrants name into English) | ||||
The Netherlands | ||||
(Jurisdiction of incorporation or organization) | ||||
Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands | ||||
(Address of principal executive office) |
||||
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: [x] Form 20-F [ ] Form 40-F | ||||
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ] | ||||
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ] | ||||
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: [ ] Yes [x] No | ||||
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): n/a |
This report comprises a copy of the following press release: - “Philips CFO updates market on implementation of strategy to become leading company in health and well-being”, dated September 14, 2011.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. |
Koninklijke Philips Electronics N.V. | ||
Date: September 14, 2011 | By: |
/s/ Eric Coutinho |
Name: | Eric Coutinho | |
Title: | General Secretary | |
Exhibit No. | Description | |
|
|
|
99 | Press release | |
Philips CFO updates market on implementation of strategy to become leading company in health and well-being
September 14, 2011
London, United Kingdom Today, Ron Wirahadiraksa, Chief Financial Officer of Royal Philips Electronics (NYSE: PHG, AEX: PHI), will give a presentation to investors and financial analysts at the Credit Suisse Capital Goods Conference, London.
In his presentation, Mr. Wirahadiraksa will discuss the opportunities and near-term actions to drive performance improvements at Philips in its progress to become a leading diversified industrial group in the field of health and well-being.
The presentation starts on Wednesday, September 14, at 09:40 a.m. UK time (10:40 a.m. CET). Handout of the presentation is available for download via this link.
For further information, please contact:
Steve Klink
Philips Corporate Communications
Tel. + 31 20 59 77415
Email: steve.klink@philips.com
About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and
well-being company, focused on improving peoples lives through timely innovations. As a world
leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into
people-centric solutions, based on fundamental customer insights and the brand promise of sense
and simplicity. Headquartered in the Netherlands, Philips employs over 120,000 employees with
sales and services in more than 100 countries worldwide. With sales of EUR 22.3 billion in 2010,
the company is a market leader in cardiac care, acute care and home healthcare, energy efficient
lighting solutions and new lighting applications, as well as lifestyle products for personal
well-being and pleasure with strong leadership positions in male shaving and grooming, portable
entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.
Forward-looking statements
This release may contain certain forward-looking statements with respect to the financial
condition, results of operations and business of Philips and certain of the plans and objectives of
Philips with respect to these items. By their nature, forward-looking statements involve risk and
uncertainty because they relate to events and depend on circumstances that will occur in the future
and there are many factors that could cause actual results and developments to differ materially
from those expressed or implied by these forward-looking statements.